Company / R&D Expense
Inogen Inc R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$20.8M
FY2025
5-year range
$9.4M / $21.9M
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $17M to $21M over the past 2 years.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +24.3%.
Improved from $17M to $21M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +14.0%
- 5-Year CAGR
- +24.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +24.3%, indicating consistent growth.
- In FY2025, r&d expense decreased 5.0% year-over-year.
- Peak r&d expense was recorded in FY2024.
- Lowest r&d expense in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.8M | -5.0% |
| FY2024 | $21.9M | +32.4% |
| FY2023 | $16.6M | +17.7% |
| FY2022 | $14.1M | +49.8% |
| FY2021 | $9.4M | +33.7% |
| FY2020 | $7.0M | +32.3% |
| FY2019 | $5.3M | +3.9% |
| FY2018 | $5.1M | +22.3% |
| FY2017 | $4.2M | +40.4% |
| FY2016 | $3.0M | +24.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026